首页> 美国卫生研究院文献>The Journal of Clinical Investigation >CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21
【2h】

CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21

机译:来自精英控制者的CD4 + T细胞通过选择性上调p21抵抗HIV-1感染

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Elite controllers represent a unique group of HIV-1–infected persons with undetectable HIV-1 replication in the absence of antiretroviral therapy. However, the mechanisms contributing to effective viral immune defense in these patients remain unclear. Here, we show that compared with HIV-1 progressors and HIV-1–negative persons, CD4+ T cells from elite controllers are less susceptible to HIV-1 infection. This partial resistance to HIV-1 infection involved less effective reverse transcription and mRNA transcription from proviral DNA and was associated with strong and selective upregulation of the cyclin-dependent kinase inhibitor p21 (also known as cip-1 and waf-1). Experimental blockade of p21 in CD4+ T cells from elite controllers resulted in a marked increase of viral reverse transcripts and mRNA production and led to higher enzymatic activities of cyclin-dependent kinase 9 (CDK9), which serves as a transcriptional coactivator of HIV-1 gene expression. This suggests that p21 acts as a barrier against HIV-1 infection in CD4+ T cells from elite controllers by inhibiting a cyclin-dependent kinase required for effective HIV-1 replication. These data demonstrate a mechanism of host resistance to HIV-1 in elite controllers and may open novel perspectives for clinical strategies to prevent or treat HIV-1 infection.
机译:精英控制者代表了一群独特的HIV-1感染者,他们在没有抗逆转录病毒疗法的情况下无法检测到HIV-1复制。但是,尚不清楚这些患者中有效的病毒免疫防御机制。在这里,我们表明,与HIV-1进展者和HIV-1阴性者相比,来自精英控制者的CD4 + T细胞对HIV-1感染的敏感性较低。对HIV-1感染的这种部分耐药性涉及较差的有效逆转录和来自前病毒DNA的mRNA转录,并且与细胞周期蛋白依赖性激酶抑制剂p21(也称为cip-1和waf-1)的强烈选择性上调相关。来自精英控制者的CD4 + T细胞中p21的实验性封锁导致病毒逆转录和mRNA产生显着增加,并导致细胞周期蛋白依赖性激酶9(CDK9)的更高酶促活性。 HIV-1基因表达的转录共激活因子。这表明p21通过抑制有效HIV-1复制所需的细胞周期蛋白依赖性激酶,成为抵抗精英控制者CD4 + T细胞中HIV-1感染的屏障。这些数据证明了精英控制者中宿主对HIV-1的抗性机制,可能为预防或治疗HIV-1感染的临床策略开辟新的前景。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号